Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroendocrine Tumors × Thalidomide × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 2 Waldenstrom Macroglobulinemia 1 Recurrence 1 Medulloblastoma 1 Lymphoma, Mantle-Cell 1 Liver Neoplasms 1 Ependymoma 1 Carcinoma, Hepatocellular 1

Interventions

lutetium Lu 177 dotatate 8 Magnetic Resonance Spectroscopy 8 Specimen Handling 7 Everolimus 5 pembrolizumab 4 lenvatinib 2 gallium Ga 68 dotatate 2 cabozantinib 2 X-Rays 2 Phantoms, Imaging 2 Octreotide 2 Nivolumab 2 Ipilimumab 2 Fluorodeoxyglucose F18 2 Etoposide 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 2 tivozanib 1 peposertib 1 pazopanib 1 lanreotide 1 guarana powder 1 gadoteridol 1 gadoterate meglumine 1 gadolinium ethoxybenzyl DTPA 1 gadodiamide 1 gadobutrol 1 gadobenic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡